Based on these findings, the 2022 ICC categorized AML with these eight sAML-type mutations together with RUNX1 mutation, which is also closely associated with sAML [7, 8] and confers poor prognosis [23], as AML with MDS-R gene mutations [9]. The gene discussed is RUNX1; the disease is acute myeloid leukemia.